- Home
- NSIT vs PRCT Comparison
NSIT vs PRCT Comparison
Compare NSIT & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSIT
- PRCT
- Stock Information
- Founded
- NSIT 1988
- PRCT 2009
- Country
- NSIT United States
- PRCT United States
- Employees
- NSIT N/A
- PRCT N/A
- Industry
- NSIT EDP Services
- PRCT Medical Specialities
- Sector
- NSIT Technology
- PRCT Health Care
- Exchange
- NSIT Nasdaq
- PRCT Nasdaq
- Market Cap
- NSIT 5.5B
- PRCT 4.7B
- IPO Year
- NSIT 1995
- PRCT 2021
- Fundamental
- Price
- NSIT $160.87
- PRCT $62.25
- Analyst Decision
- NSIT Buy
- PRCT Strong Buy
- Analyst Count
- NSIT 4
- PRCT 7
- Target Price
- NSIT $212.50
- PRCT $97.86
- AVG Volume (30 Days)
- NSIT 385.5K
- PRCT 764.2K
- Earning Date
- NSIT 02-06-2025
- PRCT 02-25-2025
- Dividend Yield
- NSIT N/A
- PRCT N/A
- EPS Growth
- NSIT N/A
- PRCT N/A
- EPS
- NSIT 6.55
- PRCT N/A
- Revenue
- NSIT $8,701,698,000.00
- PRCT $199,843,000.00
- Revenue This Year
- NSIT $3.60
- PRCT $67.07
- Revenue Next Year
- NSIT $5.24
- PRCT $40.64
- P/E Ratio
- NSIT $25.34
- PRCT N/A
- Revenue Growth
- NSIT N/A
- PRCT 71.71
- 52 Week Low
- NSIT $146.56
- PRCT $45.20
- 52 Week High
- NSIT $228.07
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- NSIT 37.38
- PRCT 29.56
- Support Level
- NSIT $163.97
- PRCT $64.04
- Resistance Level
- NSIT $168.96
- PRCT $68.38
- Average True Range (ATR)
- NSIT 4.81
- PRCT 3.30
- MACD
- NSIT -1.16
- PRCT -0.15
- Stochastic Oscillator
- NSIT 0.33
- PRCT 1.14
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.